Skip to main content
Erschienen in: Journal of Clinical Immunology 8/2019

20.08.2019 | Original Article

Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency

verfasst von: Brieanne A. Dergousoff, Joseph V. Vayalumkal, Nicola A. M. Wright

Erschienen in: Journal of Clinical Immunology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Severe combined immune deficiency (SCID) is caused by an array of genetic disorders resulting in a diminished adaptive immune system due to impaired T lymphocytes. In these patients, active infection at the time of hematopoietic transplantation has been shown to increase morbidity and mortality. To prevent transmission of infections in SCID patients, standardized infection control precautions should be implemented. An online survey regarding SCID-specific protocols was distributed through several immunodeficiency organizations. Seventy-three responses were obtained, with the majority (55%) of responses from the USA, 15% from Canada, and the remainder from 12 other countries. Only 50% of respondents had a SCID-specific infection control protocol at their center, and while a majority of these centers had training for physicians, a small minority had training for other healthcare workers such as nursing and housekeeping staff. Significant variability of infection control practices, such as in-patient precautions, required personal protective equipment (PPE), diet restrictions, visitor precautions and discharge criteria, was found between different treatment centers. There is a paucity of evidence-based data regarding the safest environment to prevent infection in SCID patients. Institutional protocols may have significant impact on infection risk, survival, family well-being, child development and cost of care. From these results, it is evident that further multi-center research is required to determine the safest and healthiest environment for these children, so that evidence-based infection control protocols for patients with SCID can be developed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1–125. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1–125.
7.
Zurück zum Zitat Magauran CE, Salgado CD. Challenges and advances in infection control of hematopoietic stem cell transplant recipients. Infect Disord Drug Targets. 2011;11:18–26.CrossRef Magauran CE, Salgado CD. Challenges and advances in infection control of hematopoietic stem cell transplant recipients. Infect Disord Drug Targets. 2011;11:18–26.CrossRef
10.
Zurück zum Zitat Wujcik D. Infection control in oncology patients. Nurs Clin N Am. 1993;28:639–50. Wujcik D. Infection control in oncology patients. Nurs Clin N Am. 1993;28:639–50.
11.
Zurück zum Zitat Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553–60.CrossRef Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553–60.CrossRef
12.
Zurück zum Zitat Buckley RH, Shiff SE, Shiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.CrossRef Buckley RH, Shiff SE, Shiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.CrossRef
17.
Zurück zum Zitat Kruger WH, Hornung RJ, Hertenstein B, Kern WV, Kroger N, Ljungman P, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res. 2001;10:895–903. https://doi.org/10.1089/152581601317210999.CrossRefPubMed Kruger WH, Hornung RJ, Hertenstein B, Kern WV, Kroger N, Ljungman P, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res. 2001;10:895–903. https://​doi.​org/​10.​1089/​1525816013172109​99.CrossRefPubMed
18.
Zurück zum Zitat Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the infectious diseases working Party of the European Group for blood and marrow transplantation. Transpl Infect Dis. 2013;15:251–8. https://doi.org/10.1111/tid.12064.CrossRefPubMed Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the infectious diseases working Party of the European Group for blood and marrow transplantation. Transpl Infect Dis. 2013;15:251–8. https://​doi.​org/​10.​1111/​tid.​12064.CrossRefPubMed
29.
Zurück zum Zitat van Tiel FH, Harbers MM, Kessels AG, Schouten HC. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenias. Ann Oncol. 2005;16:195–205.CrossRef van Tiel FH, Harbers MM, Kessels AG, Schouten HC. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenias. Ann Oncol. 2005;16:195–205.CrossRef
32.
Zurück zum Zitat Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004;25:923–8.CrossRef Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004;25:923–8.CrossRef
33.
Zurück zum Zitat Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013;122:3749–58.CrossRef Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013;122:3749–58.CrossRef
Metadaten
Titel
Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency
verfasst von
Brieanne A. Dergousoff
Joseph V. Vayalumkal
Nicola A. M. Wright
Publikationsdatum
20.08.2019
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 8/2019
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-019-00671-y

Weitere Artikel der Ausgabe 8/2019

Journal of Clinical Immunology 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.